Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CASP6 | P55212 | 3/20 | 0.42 |
| ▸ | CASP3 | P42574 | 2/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 4/20 | 0.39 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1177931 | 0.74 | HPGD (0.50) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL2340654 | 0.73 | HPGD (0.57) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL31422646 | 0.73 | HPGD (1.00) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL143970 | 0.73 | HPGD (1.00) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL29765632 | 0.72 | HPGD (0.59) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL29899602 | 0.71 | HPGD (0.68) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL2345232 | 0.71 | HPGD (0.68) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL7008036 | 0.70 | HPGD (0.62) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL11133610 | 0.70 | HPGD (0.62) | HPGDNOTUMKMT2ACASP6CASP3 | |
| SCHEMBL20062944 | 0.70 | TLR9 (0.34) | TLR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-01-23 | — | — | US | claimed |
| EP-2655360-A1 | METHOD FOR PRODUCING N-SULFONYL-SUBSTITUTED OXINDOLES | Bayer Intellectual Property GmbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012084854-A1 | METHOD FOR PRODUCING N-SULFONYL-SUBSTITUTED OXINDOLES | BAYER CROPSCIENCE AG (DE) | 2012-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140024828-A1 | Method for producing 2-(triazinylcarbonyl) sulfonanilides | AOX1, SULT1E1, CBR1 | HPGD 592/4885NOTUM 827/4885KMT2A 3234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.